Pages that link to "Q34467402"
Jump to navigation
Jump to search
The following pages link to Cirrhotic cardiomyopathy: a pathophysiological review of circulatory dysfunction in liver disease (Q34467402):
Displaying 50 items.
- Acute Kidney Injury in Patients with Cirrhosis (Q26775643) (← links)
- Cirrhotic cardiomyopathy: Implications for the perioperative management of liver transplant patients (Q26826868) (← links)
- Hepatosplanchnic circulation in cirrhosis and sepsis (Q26864350) (← links)
- Peculiar characteristics of portal-hepatic hemodynamics of alcoholic cirrhosis (Q26992215) (← links)
- Hepato-cardiac disorders (Q26997114) (← links)
- Cardiovascular dysfunction in patients with liver cirrhosis (Q27010592) (← links)
- Role of cardiovascular intervention as a bridge to liver transplantation (Q27011341) (← links)
- Relationship of 24-hour ambulatory blood pressure and heart rate with markers of hepatic function in cirrhotic patients. (Q30992956) (← links)
- IgG from patients with liver diseases inhibit mitochondrial respiration in permeabilized oxidative muscle cells: impaired function of intracellular energetic units? (Q31049485) (← links)
- SHSST cyclodextrin complex prevents the fibrosis effect on CCl₄-induced cirrhotic cardiomyopathy in rats through TGF-β pathway inhibition effects (Q33755691) (← links)
- The Correlation between Echocardiographic Findings and QT Interval in Cirrhotic Patients (Q33758733) (← links)
- Impaired cardiovascular function in primary biliary cirrhosis (Q33840627) (← links)
- Pre- and postoperative systemic hemodynamic evaluation in patients subjected to esophagogastric devascularization plus splenectomy and distal splenorenal shunt: a comparative study in schistomomal portal hypertension (Q34225488) (← links)
- High early cardiovascular mortality after liver transplantation (Q34421646) (← links)
- NT pro BNP plasma level and atrial volume are linked to the severity of liver cirrhosis (Q34934407) (← links)
- Review article: volume expansion in patients with cirrhosis (Q34992529) (← links)
- Diastolic dysfunction characterizes cirrhotic cardiomyopathy (Q35028523) (← links)
- Management of Cardiopulmonary Complications of Cirrhosis (Q35207515) (← links)
- Increased circulating pro-brain natriuretic peptide (proBNP) and brain natriuretic peptide (BNP) in patients with cirrhosis: relation to cardiovascular dysfunction and severity of disease. (Q35596013) (← links)
- Advances in critical care hepatology (Q35605215) (← links)
- Hepatopulmonary syndrome: a concern for the anesthetist? Pre-operative evaluation of hypoxemic patients with liver disease. (Q35680343) (← links)
- Arterial hypertension in cirrhosis: arterial compliance, volume distribution, and central haemodynamics (Q35760236) (← links)
- Review article: pathogenesis and pathophysiology of hepatorenal syndrome--is there scope for prevention? (Q35873829) (← links)
- Volume adaptation in chronic liver disease: on the static and dynamic location of water, salt, protein and red cells in cirrhosis (Q35888758) (← links)
- Hypertension and liver disease. (Q35940029) (← links)
- One-Year Mortality after Traumatic Brain Injury in Liver Cirrhosis Patients--A Ten-Year Population-Based Study. (Q36195323) (← links)
- Preoperative assessment of the patient with liver disease (Q36243486) (← links)
- The use of vasoconstrictors in patients with cirrhosis: type 1 HRS and beyond (Q36404275) (← links)
- Liver cirrhosis and arterial hypertension. (Q36415436) (← links)
- Cardiac and vascular changes in cirrhosis: pathogenic mechanisms (Q36415452) (← links)
- Endocannabinoids acting at CB1 receptors mediate the cardiac contractile dysfunction in vivo in cirrhotic rats (Q36426811) (← links)
- Therapy insight: Cirrhotic cardiomyopathy (Q36495176) (← links)
- The extrahepatic consequences of cirrhosis (Q36568429) (← links)
- Pathophysiological aspects of pulmonary complications of cirrhosis (Q36799915) (← links)
- Preoperative evaluation of patients with liver disease (Q36809737) (← links)
- Cardiovascular determinants of survival in cirrhosis (Q36829265) (← links)
- Contribution of mammalian target of rapamycin in the pathophysiology of cirrhotic cardiomyopathy. (Q36909237) (← links)
- Acute renal dysfunction in liver diseases (Q36975923) (← links)
- N-terminal pro B-type natriuretic peptide and the evaluation of cardiac dysfunction and severity of disease in cirrhotic patients (Q37040910) (← links)
- Cardiac troponin elevation predicts mortality in patients undergoing orthotopic liver transplantation (Q37054996) (← links)
- Post-operative hypertension, a surrogate marker of the graft function and predictor of survival in living donor liver transplant recipients: A retrospective study (Q37137971) (← links)
- Can non-invasive measurements aid clinical assessment of volume in patients with cirrhosis? (Q37157856) (← links)
- Autonomic dysfunction in cirrhosis and portal hypertension (Q37210058) (← links)
- Nitric oxide levels in chronic liver disease patients with and without oesophageal varices (Q37278258) (← links)
- Cardiac and systemic haemodynamic complications of liver cirrhosis (Q37368987) (← links)
- Diastolic dysfunction and severity of cirrhosis in nonalcoholic cirrhotic patients (Q37385716) (← links)
- Minocycline attenuates cirrhotic cardiomyopathy and portal hypertension in a rat model: Possible involvement of nitric oxide pathway (Q37447723) (← links)
- Serum lipid profile as a marker of liver impairment in hepatitis B Cirrhosis patients (Q37676748) (← links)
- Cardiovascular changes in cirrhosis: pathogenesis and clinical implications (Q37771146) (← links)
- Reversible Cardiomyopathies—A Review (Q37811399) (← links)